709649-93-4

Upstream product

• 709649-96-7 (E)-3-[4-(4-methoxy-benzyl)-2-oxo-2,3,4,5-tetrahydro-1H-pyrido[2,3-e][1,4]diazepin-7-yl]acrylic acid tert-butyl ester 
• 1309208-23-8 methyl 2-(((2-amino-5-bromopyridin-3-yl)methyl)(4-methoxybenzyl)amino)acetate 
• 123-11-5 4-methoxy-benzaldehyde 
• 20839-80-9 (4-methoxybenzylamino)acetic acid methyl ester 
• 126079-16-1 N-(4-methoxybenzylidene)glycine methyl ester 
• 335031-01-1 2-amino-5-bromo-3-(hydroxymethyl)pyridine 
• 709649-95-6 7-bromo-4-(4-methoxy-benzyl)-1,3,4,5-tetrahydro-pyrido[2,3-e][1,4]diazepin-2-one 
• 335033-38-0 2-amino-5-bromo-3-(bromomethyl)pyridine hydrobromide 
• 5345-47-1 2-aminopyridin-3-carboxylic acid 
• 23612-57-9 (2-amino-3-pyridinyl)methanol 

Relevant academic research and scientific papers

NOVEL HETEROCYCLIC ACRYLAMIDES AND THEIR USE AS PHARMACEUTICALS

The invention relates to novel heterocyclic acrylamide compounds (I), to the preparation of the compounds and intermediates used therein, to the use of the compounds as antibacterial medicaments and pharmaceutical compositions containing the compounds.

HETEROCYCLIC COMPOUNDS, METHODS OF MAKING THEM AND THEIR USE IN THERAPY

In part, the present invention is directed to antibacterial compounds of formula (I) wherein A is a bicyclic heteroaryl ring or a tricyclic ring and R2 is an heterocyclic residue; L is a bond, or L is alkyl, alkenyl or cycloalkyl.